Related references
Note: Only part of the references are listed.Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10
J. E. Allen et al.
CANCER RESEARCH (2015)
Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner
Varun V. Prabhu et al.
CANCER RESEARCH (2015)
COX-2-Independent Effects of Celecoxib Sensitize Lymphoma B Cells to TRAIL-Mediated Apoptosis
Anne-Sophie Gallouet et al.
CLINICAL CANCER RESEARCH (2014)
The angular structure of ONC201, a TRAIL pathway-inducing compound, determines its potent anti-cancer activity
Jessica Wagner et al.
ONCOTARGET (2014)
TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies
C. Gasparini et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Controversies in the Role of Radiotherapy in the Treatment of Pediatric Hodgkin Lymphoma
Meret Henry et al.
INDIAN JOURNAL OF PEDIATRICS (2013)
Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects
Joshua E. Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Targeting TRAIL Death Receptor 4 with Trivalent DR4 Atrimer Complexes
Joshua E. Allen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms
James W. Vardiman
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozitumab
Howard M. Stern et al.
CLINICAL CANCER RESEARCH (2010)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy
Norma Lynn Fox et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
TRAIL receptor signaling and therapeutics
Junaid Abdulghani et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Following TRAIL's path in the immune system
Christina Falschlehner et al.
IMMUNOLOGY (2009)
CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-κB activation and up-regulation of c-FLIP and BCl-xL
Marion Travert et al.
JOURNAL OF IMMUNOLOGY (2008)
Cooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts
Dylan Daniel et al.
BLOOD (2007)
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
Klaus W. Wagner et al.
NATURE MEDICINE (2007)
Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death
GV Georgakis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human Esophageal epithelial cells
SH Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity
MS Ricci et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
TRAIL and apoptosis induction by TNF-family death receptors
SL Wang et al.
ONCOGENE (2003)
Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines
A Mouzakiti et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells
E Ucur et al.
BRITISH JOURNAL OF CANCER (2003)
c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway
J Klefstrom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
E Cretney et al.
JOURNAL OF IMMUNOLOGY (2002)
Translocations involving c-myc and c-myc function
LM Boxer et al.
ONCOGENE (2001)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
Share Paper
